Point Designs
8
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
12.5%
1 terminated/withdrawn out of 8 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
100%
5 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
To Validate Point Mini User Needs
Role: lead
To Evaluate the Clinical Impact of the Point Powered System
Role: lead
To Assess the Utility of the Point Mini in a Clinical Take-home Study
Role: lead
To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees
Role: lead
Teleoperation Experimental Comparison With Able-bodied Subjects
Role: lead
Validation of Point Partial User Needs With Partial Finger Amputees
Role: lead
Validation of User Needs of the Point Digit With Partial Hand Amputees
Role: lead
To Assess the Utility of the Point Digit in a Clinical Take-home Study
Role: lead
All 8 trials loaded